STOCK TITAN
  1. Home
  2. Sec-filings
  3. ENVX
  4. [Form 4] Enovix Corp Insider Trading Activity

Enovix (ENVX) Chief Legal Officer receives 159,362 RSUs, total holdings 611,007

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Chakravarthy Arthi reported acquisition or exercise transactions in this Form 4 filing.

Enovix Corp Chief Legal Officer Arthi Chakravarthy received an equity award of 159,362 shares of common stock in the form of restricted stock units (RSUs). The RSUs were granted at no cash cost and will vest in 12 equal quarterly installments starting from April 1, 2026, conditioned on continued service.

After this grant, Chakravarthy is reported as holding 611,007 shares of Enovix common stock, including 409,461 shares issuable upon vesting and settlement of RSUs, 10,393 vested performance RSUs scheduled for release in March 2027, and 58,500 additional performance RSUs scheduled for releases in April 2027 and April 2028.

Positive

  • None.

Negative

  • None.
Insider Chakravarthy Arthi
Role Chief Legal Officer
Type Security Shares Price Value
Grant/Award Common Stock 159,362 $0.00 --
Holdings After Transaction: Common Stock — 611,007 shares (Direct)
Footnotes (1)
  1. Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 12 equal quarterly installments measured from April 1, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each applicable vesting date. Includes 409,461 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person, as well as: (i) 10,393 vested performance restricted stock units ("PRSUs"), which will be released to the Reporting Person in March 2027, and (ii) an aggregate of 58,500 PRSUs, 50% of which will be released in April 2027, with the remainder to be released in April 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
RSU grant size 159,362 shares Restricted stock units granted on April 1, 2026
Grant price $0.0000 per share RSU award to Chief Legal Officer
Total holdings after grant 611,007 shares Common stock position following transaction
RSUs included in holdings 409,461 shares Shares issuable upon vesting and settlement of RSUs
Vested PRSUs 10,393 shares Performance RSUs to be released in March 2027
Additional PRSUs 58,500 shares Performance RSUs, half releasing April 2027 and half April 2028
Vesting schedule length 12 quarterly installments RSUs vesting from April 1, 2026
restricted stock units ("RSUs") financial
"Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance restricted stock units ("PRSUs") financial
"Includes 409,461 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person, as well as: (i) 10,393 vested performance restricted stock units ("PRSUs"),"
vesting commencement date financial
"The RSUs will vest in 12 equal quarterly installments measured from April 1, 2026, the vesting commencement date,"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
continuous service financial
"subject to the Reporting Person's continuous service through each applicable vesting date."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chakravarthy Arthi
(Last)(First)(Middle)
C/O ENOVIX CORPORATION
3501 W. WARREN AVENUE
(Street)
FREMONT CALIFORNIA 94538
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/01/2026A159,362(1)A$0611,007(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 12 equal quarterly installments measured from April 1, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each applicable vesting date.
2. Includes 409,461 shares issuable upon the vesting and settlement of RSUs granted to the Reporting Person, as well as: (i) 10,393 vested performance restricted stock units ("PRSUs"), which will be released to the Reporting Person in March 2027, and (ii) an aggregate of 58,500 PRSUs, 50% of which will be released in April 2027, with the remainder to be released in April 2028. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.
Remarks:
/s/ Arthi Chakravarthy04/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

How do the new RSUs for Enovix (ENVX) CLO vest over time?

The 159,362 RSUs granted to Enovix Chief Legal Officer vest in 12 equal quarterly installments. Vesting begins on April 1, 2026, the vesting commencement date, and requires her continuous service with the company through each applicable quarterly vesting date to receive the underlying shares.

What RSU and PRSU awards are included in the Enovix (ENVX) CLO’s holdings?

Her reported position includes 409,461 shares from RSUs, 10,393 vested performance RSUs due for release in March 2027, and 58,500 additional performance RSUs. Of those, half are scheduled for release in April 2027 and the remaining half in April 2028, subject to award terms.